NCT04819854View on ClinicalTrials.gov

Single and Multiple Ascending Dose Study With EP395

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

April 5, 2021

Primary Completion Date

March 22, 2022

Study Completion Date

March 22, 2022

Conditions
Adult ALL
Interventions
DRUG

EP395

capsule for oral treatment

DRUG

Placebo

capsule for oral treatment

Trial Locations (1)

M23 9QZ

The Medicines Evaluation Unit (MEU) Ltd., Manchester

Sponsors
All Listed Sponsors
lead

EpiEndo Pharmaceuticals

INDUSTRY